tirzepatide drug shortage list 🚨 Alert: No Longer on FDA's As of October 2, 2024, the FDA has announced that the Tirzepatide shortage has been resolved. This means that all doses of Eli Lilly's Tirzepatide drugs removed

Updated on June 25th, 2026 Inject tirzepatide on the same day each week at any time, because consistency matters more than specific timing, with injections spaced 4 to 7 days apart if schedule adjustments are needed

By month 3 to 4 of treatment, most side effects have resolved entirely for patients who adhered to dosing guidelines and nutrition adjustments

This finding suggests that the primary mechanism of GLP-1RAs in the retina is likely direct neuroprotection

Monitoring during this phase ensures that the body continues to respond well to the medication

About Educational Initiatives Given the critical connection between diabetes and cardiovascular disease, Boehringer Ingelheim and Eli Lilly and Company are committed to providing a wide range of diabetes therapies along with programs and support to raise awareness, understanding and action toward reducing the impact of cardiovascular disease in people with type 2 diabetes

Use our peptide calculator or the reconstitution calculator to double check your math